Detalles de la búsqueda
1.
Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial.
Int J Cancer
; 139(12): 2812-2826, 2016 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27541373
2.
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.
Lancet Oncol
; 16(7): 775-86, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26071347
3.
Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIA.
J Infect Dis
; 210(4): 517-34, 2014 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24610876
4.
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia.
Int J Gynecol Cancer
; 23(1): 148-56, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23221730
5.
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
Lancet Oncol
; 13(1): 100-10, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22075170
6.
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
Lancet Oncol
; 13(1): 89-99, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22075171
7.
Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial.
Gynecol Oncol
; 127(3): 440-50, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22940493
8.
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.
Lancet
; 369(9580): 2161-2170, 2007 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-17602732
9.
Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.
Clin Vaccine Immunol
; 22(4): 361-73, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25651922
10.
Post hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNA.
Clin Vaccine Immunol
; 22(2): 235-44, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25540273
11.
The endometrial cancer risk scoring / Philippine Journal of Obstetrics and Gynecology
Philippine Journal of Obstetrics and Gynecology
; : 90-94, 2000.
Artículo
en Inglés
| WPRIM | ID: wpr-732062
Resultados
1 -
11
de 11
1
Próxima >
>>